Health Advocate for Children After Liver Transplant
(HEAL-Tx:RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist families of children who have recently undergone a liver transplant by providing support through a Health Advocate. The advocate will help families find and apply for community resources, coordinate healthcare appointments, and address any challenges they encounter. Families in the control group will receive a list of local resources and a follow-up call. The trial seeks families with children under 18 who have had a liver transplant within the last 90 days and are experiencing financial hardships. Participants should be able to communicate in English or Spanish and have access to a smartphone for virtual visits. As an unphased trial, this study offers families the opportunity to receive personalized support and resources during a challenging time.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on providing support and resources rather than changing medical treatments.
What prior data suggests that this Health Advocate intervention is safe for children after liver transplant?
Research has shown that the Health Advocate program is generally safe for families of children who have had a liver transplant. In this program, a Health Advocate assists families in finding and using local resources, communicates any concerns to healthcare providers, and guides them through the healthcare system.
No specific information exists on negative effects or side effects from having a Health Advocate. Since this program emphasizes support and resources rather than medications or medical treatments, it is expected to be safe. Previous studies on similar programs have shown that meeting social needs can improve health without causing harm.
Overall, the Health Advocate program aims to support families without adding health risks.12345Why are researchers excited about this trial?
Researchers are excited about the Health Advocate intervention for children post-liver transplant because it offers a personalized support system for caregivers, something not typically found in standard care. Unlike traditional methods, which might include basic resource guides or sporadic check-ins, this intervention provides a tailored, 90-day program designed to address the specific needs of each caregiver. This individualized approach aims to improve the overall well-being and health outcomes for children by empowering their caregivers with the necessary tools and support.
What evidence suggests that the Health Advocate intervention is effective for children after liver transplant?
Research shows that children from challenging social backgrounds are more likely to experience problems after a liver transplant. Studies have found that improving social conditions can enhance health outcomes for these children. This trial tests the Health Advocate program as one of the interventions. The program helps families access local resources, reducing stress and improving care organization. Previous efforts to increase social support have led to better transplant outcomes, such as higher survival rates. Early evidence suggests that a Health Advocate can assist families in managing healthcare and improve children's recovery after a liver transplant.12678
Who Is on the Research Team?
Sharad Wadhwani, MD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for families with children who have received a liver transplant. It's designed to help them navigate the healthcare system and access community resources effectively.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline interviews and assessments are conducted for both treatment and control arms
Treatment
Participants in the treatment arm receive a 90-day Health Advocate intervention; control arm receives a printed handout and a follow-up call at 45 days
Follow-up
Participants are monitored for outcomes and experiences with the intervention, including interviews at 90 days and data extraction at 1 and 2 years
What Are the Treatments Tested in This Trial?
Interventions
- Health Advocate
Trial Overview
The study is testing a 90-day program where a Health Advocate assists families post-liver transplant versus just giving them a handout with resource contacts. The goal is to see if having personalized support makes a difference.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The caregiver will receive 90-days of tailored health advocate intervention
The caregiver will receive a printed sheet of resources once and a follow-up call at the 45-day timepoint with a reminder of the suggested resources.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Citations
Health Advocate for Children After Liver Transplant
HEAL-Tx trial is a Type 1 hybrid effectiveness-implementation trial across 6 U.S. transplant centers (UCSF, Seattle Children's Hospital, ...
RePORT RePORTER - National Institutes of Health (NIH) |
Children facing social adversity, and those from socioeconomically deprived backgrounds have increased risk of graft failure and death following transplant.
Addressing social adversity to improve outcomes for ...
We lay out a strategy to develop and test interventions to address social adversity for children undergoing liver transplant.
Opportunities to Improve Liver Transplantation Outcomes ...
While post-transplant outcomes are excellent and 5-year pediatric patient survival exceeds 90%, much clinical and research effort in pediatric liver ...
5.
trial.medpath.com
trial.medpath.com/clinical-trial/ce7b5938d73aa6d8/nct07279350-health-advocate-children-liver-transplantHealth Advocate for Children After Liver Transplant | MedPath
The HEAL-Tx is a 90-day intervention, in which a Health Advocate works with eligible families to identify and apply for community-based ...
NCT05700799 | HEalth Advocate for Liver Transplant - Pilot
The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food ...
Patient-centered research in pediatric transplant: Engaging ...
Pediatric liver transplant (LT) recipients navigate a lifelong journey that includes constant monitoring and challenges.
Health Advocate for Adolescent Liver Transplant Recipients
This trial tests a new support system to assist young people transitioning from pediatric to adult care after a liver transplant.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.